urothelial cancer

Showing NaN - NaN of 7

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Urothelial Cancer Trial in Worldwide (Nivolumab, Ipilimumab, Gemcitabine)

Recruiting
  • Urothelial Cancer
  • Nivolumab
  • +4 more
  • Birmingham, Alabama
  • +196 more
Jan 17, 2023

Advanced Malignancies, NSCLC, Ovarian Cancer Trial in Worldwide (Avelumab, Lorlatanib, Talazoparib)

Recruiting
  • Advanced Malignancies
  • +4 more
  • Fayetteville, Arkansas
  • +61 more
Jan 10, 2023

Urothelial Cancer Trial in Worldwide (MEDI4736 (Durvalumab), Tremelimumab, Cisplatin)

Active, not recruiting
  • Urothelial Cancer
  • MEDI4736 (Durvalumab)
  • +4 more
  • Los Angeles, California
  • +221 more
Nov 2, 2022

Urothelial Cancer Trial in Worldwide (Avelumab, Best Supportive Care, Following the planned interim analysis for this study:

Active, not recruiting
  • Urothelial Cancer
  • Avelumab
  • +2 more
  • Aurora, Colorado
  • +370 more
Oct 24, 2022

Urothelial Cancer Trial in Worldwide (Erdafitinib, Vinflunine, Docetaxel)

Recruiting
  • Urothelial Cancer
  • Anchorage, Alaska
  • +414 more
Jul 14, 2022

Urothelial Cancer Trial in Worldwide (TKI258)

Completed
  • Urothelial Cancer
  • La Jolla, California
  • +25 more
Dec 11, 2020